MedPath

Southeastern Diabetes Initiative Clinical Intervention

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: Extension of Care
Registration Number
NCT01965639
Lead Sponsor
Duke University
Brief Summary

The purpose of the Southeastern Diabetes Initiative Clinical Intervention is to augment existing standard of care in an effort to (1) improve population level diabetes management, health outcomes and quality of life for diagnosed and undiagnosed adults living with Type 2 Diabetes Mellitus, (2) reduce disparities in diabetes management, health outcomes and quality of life for adults living with Type 2 Diabetes Mellitus, and (3) reduce healthcare costs associated with Type 2 Diabetes Mellitus.

Detailed Description

Clinical care will be delivered by a multidisciplinary team including (but not limited to) an physician, nurse practitioner, dietician, pharmacist, licensed clinical social worker (LCSW), case manager, health educator and a community health worker. Care will be delivered in community settings including home visits and community based clinics. With the exception of specific surveys (listed in the Study Intervention section) all data are being collected for the purpose of delivery of standard preventive care and clinical care. The population group will include patients diagnosed with Type 2 Diabetes Mellitus in four Southern United States counties, meeting certain inclusion criteria, and deemed "high risk" as determined by a set of standard criteria or a risk algorithm run on secondary data.

The investigators plan to characterize patients diagnosed or at risk for diabetes mellitus, and allow more detailed knowledge of their health than is provided by standard public health data. The investigators will use descriptive, parametric and non-parametric statistics to describe baseline characteristics (demographics and clinical measures of disease severity) of the sample and will compare responders and dropouts on independent and dependent variables, report any significant differences, and include this in the interpretation of results.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
648
Inclusion Criteria
  • Adults >=18yrs
  • Diagnosis of Type 2 diabetes
  • Reside in Durham County, NC, Cabarrus County, NC, Quitman County, MS or Mingo County, WV or the neighboring areas and receive the majority of their healthcare in the four listed counties.
  • Have capacity to give consent (or have a surrogate legally authorized representative or caregiver provide consent on their behalf).
  • Defined as high risk by the risk algorithm or their primary care clinician.
  • Referral from the primary care clinician or patient's medical home if one has been designated.
Read More
Exclusion Criteria
  • Lack capacity to make decisions and do not have a surrogate with authority to make health care decisions.
  • Have a terminal illness with a life expectancy of 6 months or less
  • Diagnosis of Type 1 diabetes or gestational diabetes
  • Currently pregnant (confirmed via self-report and/or medical record)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
High Risk groupExtension of CareExtension of Care
Primary Outcome Measures
NameTimeMethod
MortalityUp to 24 months
Secondary Outcome Measures
NameTimeMethod
Change in blood glucoseBaseline, 6, 12, 18, and 24 months
Change in Medication AdherenceBaseline, 6, 12, 18, and 24 months

As measured by the Morisky Medication Adherence Score

Change in HbA1cBaseline, 6, 12, 18, and 24 months
Change in patient-reported outcomesBaseline, 6, 12, 18, and 24 months

Includes results from PHQ 2, PAM-13, PROMIS 9, and REALM-SF surveys

Rate of health services utilizationup to 24 months

As measured by inpatient hospital admissions and emergency department visits

Change in blood lipidsBaseline, 6, 12, 18, and 24 months

Measurements include total cholesterol, HDL, LDL, triglycerides

Change in blood pressureBaseline, 6, 12, 18, and 24 months
Incidence of micro- and macro-vascular complicationsUp to 24 months

Includes retinopathy, neuropathy, kidney disease, cardiovascular disease

Trial Locations

Locations (4)

Cabarrus Health Alliance

🇺🇸

Kannapolis, North Carolina, United States

Durham County Department of Public Health

🇺🇸

Durham, North Carolina, United States

Williamson Health and Wellness Center

🇺🇸

Williamson, West Virginia, United States

Mississippi Public Health Institute

🇺🇸

Madison, Mississippi, United States

© Copyright 2025. All Rights Reserved by MedPath